Overview

Evaluation the Safety of hemay005 Tablets

Status:
RECRUITING
Trial end date:
2025-04-30
Target enrollment:
Participant gender:
Summary
Explore the influence of different administration methods (titration/non-titration) of Hemay005 tablets on the incidence of adverse reactions.
Phase:
PHASE1
Details
Lead Sponsor:
Anhui Hemay Pharmaceutical Co., Ltd
Treatments:
Hemay005